437 related articles for article (PubMed ID: 18505348)
1. Health-related quality of life in multiple myeloma survivors treated with high dose chemotherapy followed by autologous peripheral blood progenitor cell transplantation: a retrospective analysis.
Slovacek L; Slovackova B; Pavlik V; Hrstka Z; Macingova Z; Jebavy L; Horacek JM
Neoplasma; 2008; 55(4):350-5. PubMed ID: 18505348
[TBL] [Abstract][Full Text] [Related]
2. Global quality of life in patients who have undergone the hematopoietic stem cell transplantation: finding from transversal and retrospective study.
Slovacek L; Slovackova B; Jebavy L
Exp Oncol; 2005 Sep; 27(3):238-42. PubMed ID: 16244589
[TBL] [Abstract][Full Text] [Related]
3. Quality of life in adult patients treated with peripheral blood progenitor cell transplantation: the effect of selected psychosocial, demographics and health aspects on quality of life: a retrospective analysis.
Slovácek L; Slovácková B; Jebavý L; Pavlík V
Acta Medica (Hradec Kralove); 2007; 50(2):119-24. PubMed ID: 18035749
[TBL] [Abstract][Full Text] [Related]
4. [Health and psychosocial aspects of quality of life in patients undergoing autologous progenitor stem cell transplantation].
Slovácek L; Slováková B; Jebavý L
Cas Lek Cesk; 2006; 145(12):949-52; discussion 953-4. PubMed ID: 17323618
[TBL] [Abstract][Full Text] [Related]
5. Quality of life and arterial endovascular intervention by means of balloon angioplasty.
Slovacek L; Slovackova B; Chovanec V; Jebavy L
Int Angiol; 2008 Oct; 27(5):396-400. PubMed ID: 18974702
[TBL] [Abstract][Full Text] [Related]
6. Changes in quality-of-life and psychosocial adjustment among multiple myeloma patients treated with high-dose melphalan and autologous stem cell transplantation.
Sherman AC; Simonton S; Latif U; Plante TG; Anaissie EJ
Biol Blood Marrow Transplant; 2009 Jan; 15(1):12-20. PubMed ID: 19135938
[TBL] [Abstract][Full Text] [Related]
7. [High-dose chemotherapy with autologous peripheral blood stem cell transplantation for the treatment of multiple myeloma refractory to conventional chemotherapy].
Shimokawa T; Kajiguchi T; Saito M; Kojima Y; Takeyama H
Gan To Kagaku Ryoho; 2003 Feb; 30(2):251-4. PubMed ID: 12610874
[TBL] [Abstract][Full Text] [Related]
8. Complete remission status before autologous stem cell transplantation is an important prognostic factor in patients with multiple myeloma undergoing upfront single autologous transplantation.
Kim JS; Kim K; Cheong JW; Min YH; Suh C; Kim H; Jo DY; Ryoo HM; Yoon SS; Lee JH;
Biol Blood Marrow Transplant; 2009 Apr; 15(4):463-70. PubMed ID: 19285634
[TBL] [Abstract][Full Text] [Related]
9. Individual quality of life of patients undergoing autologous peripheral blood stem cell transplantation.
Frick E; Borasio GD; Zehentner H; Fischer N; Bumeder I
Psychooncology; 2004 Feb; 13(2):116-24. PubMed ID: 14872530
[TBL] [Abstract][Full Text] [Related]
10. Autologous transplantation in elderly patients with multiple myeloma: are we asking the right questions?
Klepin HD; Hurd DD
Bone Marrow Transplant; 2006 Nov; 38(9):585-92. PubMed ID: 16953209
[TBL] [Abstract][Full Text] [Related]
11. High-dose chemotherapy and autologous peripheral blood stem cell transplantation in high-risk multiple myeloma.
Murakami H; Fujii H; Inaba T; Shimazaki C; Okamoto S; Miwa A; Sawamura M; Abe M; Chou T; Asaoku H; Kitahara Y; Hayashi K; Kosaka M; Togawa A; Takatsuki K;
Eur J Haematol; 2004 Sep; 73(3):169-73. PubMed ID: 15287913
[TBL] [Abstract][Full Text] [Related]
12. The effect of selected health, demographic and psychosocial aspects on quality of life in patients with peripheral arterial occlusive disease--a prospective analysis.
Slovácek L; Slováková B; Chovanec V; Vacková P; Kaslíková M; Bohutínská H; Jebavý L
Acta Medica (Hradec Kralove); 2007; 50(2):125-7. PubMed ID: 18035750
[TBL] [Abstract][Full Text] [Related]
13. Quality of life of long-term adult survivors of autologous bone marrow transplantation.
Whedon M; Stearns D; Mills LE
Oncol Nurs Forum; 1995; 22(10):1527-35; discussion 1535-7. PubMed ID: 8577621
[TBL] [Abstract][Full Text] [Related]
14. Interpretation of quality of life scores in multiple myeloma by comparison with a reference population and assessment of the clinical importance of score differences.
Gulbrandsen N; Hjermstad MJ; Wisløff F;
Eur J Haematol; 2004 Mar; 72(3):172-80. PubMed ID: 14962235
[TBL] [Abstract][Full Text] [Related]
15. Health related quality of life in patients with multiple myeloma undergoing a double transplantation.
Uyl-de Groot CA; Buijt I; Gloudemans IJ; Ossenkoppele GJ; Berg HP; Huijgens PC
Eur J Haematol; 2005 Feb; 74(2):136-43. PubMed ID: 15654905
[TBL] [Abstract][Full Text] [Related]
16. High-dose chemotherapy and autologous hematopoietic stem cell transplantation in myeloma patients under the age of 65 years.
Mehta J; Singhal S
Bone Marrow Transplant; 2007 Dec; 40(12):1101-14. PubMed ID: 17680020
[TBL] [Abstract][Full Text] [Related]
17. Comparative survival, quality of life and cost-effectiveness of intensive therapy with autologous blood cell transplantation or conventional chemotherapy in multiple myeloma.
Henon P; Donatini B; Eisenmann JC; Becker M; Beck-Wirth G
Bone Marrow Transplant; 1995 Jul; 16(1):19-25. PubMed ID: 7581122
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of diverse high-dose regimens followed by autologous peripheral blood stem cell transplantation in consecutive multiple myeloma patients: a single-centre analysis over a 12-year period.
Haas PS; Bauchmüller K; Kühnemund A; Finke J; Ihorst G; Engelhardt M
Ann Hematol; 2006 Mar; 85(3):191-3. PubMed ID: 16365747
[No Abstract] [Full Text] [Related]
19. [Health Status of the German population: results of a representative survey using the EuroQol questionnaire].
König HH; Bernert S; Angermeyer MC
Gesundheitswesen; 2005 Mar; 67(3):173-82. PubMed ID: 15789280
[TBL] [Abstract][Full Text] [Related]
20. Combinations of cytogenetics and international scoring system can predict poor prognosis in multiple myeloma after high-dose chemotherapy and autologous stem cell transplantation.
Inamoto Y; Kurahashi S; Imahashi N; Fukushima N; Adachi T; Kinoshita T; Tsushita K; Miyamura K; Naoe T; Sugiura I
Am J Hematol; 2009 May; 84(5):283-6. PubMed ID: 19338045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
